Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
Chlebowski
Rowan T
RT
Prentice
Ross L
RL
D000368:Aged; D001943:Breast Neoplasms / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology* / Q000235:genetics; D016022:Case-Control Studies; D015986:Confounding Factors, Epidemiologic; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D019398:Genes, BRCA1; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D017698:Postmenopause; D011372:Progestins / Q000009:adverse effects; D012107:Research Design; D018570:Risk Assessment; D012307:Risk Factors
D004967:Estrogens; D011372:Progestins